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Gas-phase complexes of triply charged metal ions with peptides may be readily produced
using electrospray ionization, including for small peptides such as bradykinin and peptides
with no basic residues such as insulin chain A. Attachment without charge-reduction is
demonstrated for all trications studied: La3, Al3, Ga3, Fe3, V3, and Cr3. The intensities
of adducts are often comparable to, or even exceed, those of protonated analogs in any charge
state. (J Am Soc Mass Spectrom 2004, 15, 406–408) © 2004 American Society for Mass Spectrometry
Gas-phase complexes of multiply charged metalcations with organic and biological moleculeshave become topical over the last decade. In
part, this is due to novelty: these systems had essen-
tially been inaccessible for experimentation until the
1990s. A large disparity between the 2nd Ionization
Energies (IE) of most metals (15–22 eV for divalent ones
except Ca, Sr, and Ba) and 1st IE of typical organic
ligands (8–13 eV) generally causes reduction of diposi-
tive elemental cations in binary collisions with neutrals.
This normally prevents a sequential ligation of metal
dications in the way standard for singly-charged spe-
cies: by passage through molecular vapor [1]. The
situation is yet worse for trications, as the 3rd IE (IE3) of
trivalent metals exceed 19 eV. The advent of electros-
pray (ESI) [2] had enabled the production of gas-phase
ligated multiply charged metal ions by transferring
them directly from solutions of metal salts in a ligand
solvent or appropriate medium containing that ligand
[3–13]. Alternatively, one could generate ligated neu-
trals or monocations as usual, then raise the charge, e.g.,
via an energetic electron impact [14, 15]. Microsolvation
of metal polycations has now been reported for water
and many common organic ligands, including alcohols,
ethers, ketones, sulfoxides, nitriles, amides, and aro-
matic compounds. However, almost all this work was
for doubly charged species. With a single exception of
aldol [9], complexes for trications were observed for few
aprotic ligands only—acetone, dimethyl sulfoxide, di-
methyl formamide, and acetonitrile [10–13]. Save for
DMSO [10], all these were limited to rare-earth metals
that have inordinately low IE3.
There has also been much interest in amino acids,
peptides, and other biomolecules cationized by metal
ions. Such complexes often fragment along the path-
ways that depend on the metal but differ from those for
protonated analogs, which sometimes is of analytical
utility. For example, lithiated and sodiated peptides
eliminate the C-terminal residue [16, 17] (C-terminal
sequencing) or cleave at the aspartic acid, if present [18].
Argentinated peptides exhibit a “triplet” product pat-
tern that substantially simplifies their sequencing [19,
20]. When bound to Zn2, histidine-containing peptides
fragment at that residue [21]. Further research into how
metal ions coordinate various peptides and modify
their dissociation should reveal new phenomena useful
in crafting sequencing strategies. However, peptide
metalation has been reported only for monocations (of
alkali metals and Ag) [22–24] and dications of divalent
elements (Ca, Mn, Zn, Cu, Ni, Co) [21, 25–28]. No
peptides associated with tripositive metal ions have
been observed to date. Given that trications in gas-
phase complexes are reduced by protic ligands (except
for the special case of aldol [9], and only rare-earth ions
are not reduced even then), one might expect metal
trications to be incompatible with peptides. On the
other hand, large enough protonated peptides routinely
carry charges of 3 and higher, though the protons
attach at different sites.
This contribution demonstrates a wholesale compl-
exation of peptides with metal trications, including
those of the elements with highest IE3 values. Most
experiments were performed using the Finnigan TSQ
7000 ESI/triple quadrupole system. Metalated peptides
were generated from aqueous peptide solutions (0.1
mM) doped with trivalent metal salts (0.05 mM).
Nitrates were used for all metals except vanadium:
V(NO3)3 was not available and VCl3 was substituted.
The ESI needle was at 4 kV, sheath gas pressure was
50 psi, and auxiliary gas was off. The heated capillary
was at 200 °C. The voltage drop in lens region was
nominal, 7 V. The infusion rate was 5 l/min. The
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peptides tried were bradykinin (Arg-Pro-Pro-Gly-Phe-
Ser-Pro-Phe-Arg, 1060 Da), human angiotensin I (Asp-
Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu, 1296 Da), neuro-
tensin (pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-
Tyr-Ile-Leu, 1673 Da), and insulin chain A (Gly-Ile-Val-
Glu-Gln-Cys(SO3H)-Cys(SO3H)-Ala-Ser-Val-Cys(SO3H)-
Ser-Leu-Tyr-Gln-Leu-Glu-Asn-Tyr-Cys(SO3H)-Asn,
2531 Da). To achieve a higher mass resolution and
accuracy, some measurements were made employing
the Waters/Micromass ESI/Q/TOF instrument. Unlike
the TSQ with a regular ESI, this was run with a
nanospray source that operates at 1 kV, has a much
lower flow rate, and uses no sheath gas. Despite sub-
stantially different source conditions, the two instru-
ments produced very similar data.
The ESI of (undoped) aqueous solutions generated
customary (H)n(peptide) ions with n  1–3 (bradyki-
nin) and n  2, 3 (angiotensin and neurotensin). Lan-
thanum has the lowest IE3 of all non-radioactive ele-
ments (19.2 eV), so the first set of experiments involved
La3. Ions of La3(peptide) composition were immedi-
ately observed for all three peptides. The data for
neurotensin are presented in Figure 1, top panel. The
intensity of metalated ions matches and often exceeds
that of protonated analogs. This is potentially impor-
tant, as the analytically revealing fragmentation pat-
terns of metalated peptides are often of limited practical
benefit because of low precursor abundance. For exam-
ple, the yield of Ag complexed peptides in ESI tends to
be 10 times below that of protonated species [19]. The
efficiency of La3 addition might be related to high
polarization of peptide by the triple charge, resulting in
a stronger bonding. Addition of two metals, forming
[La2(peptide™3H)]
3, proceeds in good yield as well.
The [La(peptide™H)]2 stoichiometry is also present as a
minor product. Note that this feature is an order-of-
magnitude weaker than (H)2(peptide), as is standard
when peptides add metal mono- or dications.
Each of the three peptides above contains at least two
basic residues: two arginines (bradykinin and neuroten-
sin), and arginine and histidine (angiotensin). This
raises the question whether a facile complexation of
metal trications is limited to peptides with basic side
chains. To test that, we have probed insulin chain A—a
peptide with no basic side chains but four highly acidic
cysteic acid residues. The attachment of La3 to this
peptide (Figure 1, bottom panel) has proven as efficient
as that to neurotensin.
Complexation of the doubly (triply) charged metal
cations with organic molecules generally becomes more
challenging as the 2nd (3rd) IE of the metal increases,
because of the growing propensity for charge reduction.
For trications, the attachment to some ligands could be
achieved only for the Group 3 elements, which have IE3
below 25 eV [9, 13]. To find out if this holds for
peptides, La(NO3)3 in the aqueous neurotensin solution
was replaced by the salts of trivalent metals outside of
Group 3 with high IE3. In the order of increasing IE3,
those were Al (28.5 eV), V (29.3 eV), Ga (30.7 eV), Fe
(30.7 eV), and Cr (31.0 eV). These values are 9–12 eV
above the IE3 of La. M3(neurotensin) species were
found for all metals above, the examples of Ga and Fe
are shown in Figure 2. However, their intensities rela-
tive to those of (H)3(neurotensin) ions were less than
they were for La. In particular, yields of metalated
Figure 1. Q1 mass spectral windows for aqueous neurotensin
(top panel, TSQ 7000) and insulin chain A (bottom panel, Q/TOF)
doped with La(NO3)3. Symbol “Pe” stands for peptide. Labels for
trications are underlined.
Figure 2. Q1 mass spectral windows (TSQ 7000) for aqueous
neurotensin doped with Ga(NO3)3 (left panel) and Fe(NO3)3 (right
panel). Nomenclature follows that in Figure 1.
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peptides did not exceed those of the triply protonated
ones. Still M3(neurotensin) peaks were prominent for
all metals, typically 10–50% of the (H)3(neurotensin)
features. For metals other than La, no clear correlation
between IE3 and the efficiency of M3(neurotensin)
formation was observed, perhaps due to a narrow range
of IE3 values for the elements considered.
We have performed some preliminary experiments
on the MS/MS of M3(peptide) ions that we produced.
The example of La3(neurotensin) is presented in Fig-
ure 3, bottom panel. Many fragments mirror those of
(H)3(neurotensin) (Figure 3, top panel) under the same
conditions, but two significant charged products have
no apparent analogs in the CID of protonated precur-
sor. Much further work is needed to understand the
dissociation of M3(peptide) ions and investigate its
dependence on the metal nature. (Dissociation path-
ways of M3 complexes with simple organic ligands
such as DMSO are remarkably metal-specific [10].)
In summary, this communication demonstrates the
formation of gas-phase complexes of peptides with
metal trications using ESI. These adducts are abundant,
in some cases more intense than protonated species in
any charge state. The attachment has been observed for
all peptides and metals tried, namely four peptides
(including a highly acidic one with no basic residues)
and six metals: La, Al, V, Ga, Fe, and Cr. These elements
are representative of trivalent metals: They encompass
both main group and transition metals, and include
metals with IE3 ranging from the lowest (La, 19 eV) to
nearly the highest (Cr, 31 eV). Three of the peptides
tried have 9–13 residues, leading to the conclusion of
ubiquitous attachment of metal trications to peptides
containing 10 residues. This is the characteristic size
for peptides in tryptic and other common digests that
are routinely sequenced in proteomics applications [19,
20, 29, 30]. What the fragmentation pathways are for
peptide complexes with metal trications and whether
they could be of analytical utility remains to be seen.
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Figure 3. CID spectra (Q/TOF) of (H)3(neurotensin) (top panel)
and La3(neurotensin) (bottom panel) measured under identical
conditions. The two question marks in the MS/MS spectrum of
La3(neurotensin) label the unassigned peaks at m/z  570.3 and
m/z  670.1.
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